News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

National Institutes of Health (NIH) Funds Discovery of New Influenza Inhibitors by Integral Molecular, Inc.


9/2/2008 11:08:27 AM

PHILADELPHIA--(BUSINESS WIRE)--Integral Molecular, Inc. initiates a federally-funded program to discover new drugs to combat influenza infection. Sponsored by the National Institute of Allergy and Infectious Diseases, Integral Molecular’s R&D program will utilize its proprietary Lipoparticle technology to discover new ways of inhibiting M2, a critical viral ion channel. The M2 ion channel is a validated drug target for all strains of influenza, including the most dangerous H5N1 pandemic strains. Each year, influenza is responsible for 3 to 5 million cases of severe illness and up to 500,000 deaths.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES